OMX30 1 642 0,8%  OMXH25 4 024 1,2%  OMXC20 989 0,1%  Dow 20 938 0,2%  Nas 5 703 0,1%  EUR 9,7376 -0,3%  USD 8,7075 0,1%  Olja 54,2 0,8%  Guld 1 251 -0,7% 

Edwards Lifesciences Aktie

113,54USD -0,51USD -0,45%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Edwards Lifesciences Chart - 1 År - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 32,30 33,65 29,80 26,52 23,72
Resultat/aktie 2,89 3,54 3,99 4,49 5,02

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 113,54
-0,4%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Realtidskurs Edwards Lifesciences Corp.

Bid
113,51
USD
Ask
113,54
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 113,54 USD -0,51 -0,45 %
Kurstid 21:59:58
Datum 23.05.2017
Öppning 113,99
Gårdagen 114,05
Dagshögsta 114,17
Dagslägsta 113,00
52 v. högsta 121,74
52 v. lägsta 81,12
52 v. perf.
Volym (Antal) 60 209
Börsvärde (SEK) 207,24 Mrd
Börsen
Kurs för 113,54 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 988,65 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 207,24 Mrd
Free float % 99,20
Antal aktier mio. 209,80
Cashflow/aktie i lokal valuta 3,18
Bokvärde/aktie i lokal valuta 12,57
60 dagar vola 33,94
PBV 7,43

Edwards Lifesciences Historiska kurser

2017-05-22 114,05 81 468
2017-05-19 112,90 64 935
2017-05-18 111,94 90 261
2017-05-17 111,87 96 395
2017-05-16 113,70 167 374